← Leaderboards
Cailin Deal
Massachusetts General Hospital
$164,508
Attributed
$164,508
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $59.2K · FY2016–18$100K$75K$50K$25K$0
'16
'17
'18
Funding mix
By agency
NIH$164,508 · 1
By mechanism
F32$164,508 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Mathias Lichterfeld$34,368,889
- Jessica Elizabeth Haberer$14,425,308
- Guillermo J. Tearney$42,608,505
- Athe M. Tsibris$17,945,517
- Richard T D'aquila$62,924,506
Others in their field
Top investigators on “Clinically Relevant”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$347,663,527
- Chanza Baytop · Westat, Inc.$271,217,917
- Lawrence Corey · Fred Hutchinson Cancer Center$225,946,688
- Barton F Haynes · Duke University$218,783,682
Research focus
Clinically RelevantClinical ResearchAcuteClinical EfficacyActive ControlAlternative TherapiesAnimal ModelAnimalsAdeno-Associated Viral VectorAntigensAdherenceAntiviral TherapyBaseBiologyBone MarrowBypassCd4 Positive T LymphocytesCell CountAntibodiesCellsCessation Of LifeCharacteristicsAnti-Retroviral AgentsClinical Trials
Grant awards (3)
The Use of Monoclonal Antibodies Delivered by Viral Vector as an HIV-1 Therapeutic$49,224
F32 · FY2018 · AI · contact PI
The Use of Monoclonal Antibodies Delivered by Viral Vector as an HIV-1 Therapeutic$59,166
F32 · FY2017 · AI · contact PI
The Use of Monoclonal Antibodies Delivered by Viral Vector as an HIV-1 Therapeutic$56,118
F32 · FY2016 · AI · contact PI